Your browser doesn't support javascript.
loading
Near-Infrared Light Activated Formulation for the Spatially Controlled Release of CRISPR-Cas9 Ribonucleoprotein for Brain Gene Editing.
Simões, Susana; Lino, Miguel; Barrera, Angela; Rebelo, Catarina; Tomatis, Francesca; Vilaça, Andreia; Breunig, Christopher; Neuner, Andrea; Peça, João; González, Ricardo; Carvalho, Alexandra; Stricker, Stefan; Ferreira, Lino.
  • Simões S; CNC-Centre for Neuroscience and Cell Biology of University of Coimbra, Portugal.
  • Lino M; Institute of Interdisciplinary Research of University of Coimbra, Portugal.
  • Barrera A; CNC-Centre for Neuroscience and Cell Biology of University of Coimbra, Portugal.
  • Rebelo C; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Tomatis F; CNC-Centre for Neuroscience and Cell Biology of University of Coimbra, Portugal.
  • Vilaça A; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Breunig C; CNC-Centre for Neuroscience and Cell Biology of University of Coimbra, Portugal.
  • Neuner A; Institute of Interdisciplinary Research of University of Coimbra, Portugal.
  • Peça J; CNC-Centre for Neuroscience and Cell Biology of University of Coimbra, Portugal.
  • González R; Institute of Interdisciplinary Research of University of Coimbra, Portugal.
  • Carvalho A; CNC-Centre for Neuroscience and Cell Biology of University of Coimbra, Portugal.
  • Stricker S; Institute of Interdisciplinary Research of University of Coimbra, Portugal.
  • Ferreira L; Epigenetic Engineering, Institute of Stem Cell Research, Helmholtz Zentrum, Germany.
Angew Chem Int Ed Engl ; 63(21): e202401004, 2024 05 21.
Article en En | MEDLINE | ID: mdl-38497898
ABSTRACT
The CRISPR/Cas9 system has emerged as a promising platform for gene editing; however, the lack of an efficient and safe delivery system to introduce it into cells continues to hinder clinical translation. Here, we report a rationally designed gene-editing nanoparticle (NP) formulation for brain applications an sgRNACas9 ribonucleoprotein complex is immobilized on the NP surface by oligonucleotides that are complementary to the sgRNA. Irradiation of the formulation with a near-infrared (NIR) laser generates heat in the NP, leading to the release of the ribonucleoprotein complex. The gene-editing potential of the formulation was demonstrated in vitro at the single-cell level. The safety and gene editing of the formulation were also demonstrated in the brains of reporter mice, specifically in the subventricular zone after intracerebral administration and in the olfactory bulb after intranasal administration. The formulation presented here offers a new strategy for the spatially controlled delivery of the CRISPR system to the brain.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Encéfalo / Sistemas CRISPR-Cas / Edición Génica / Rayos Infrarrojos Límite: Animals / Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Encéfalo / Sistemas CRISPR-Cas / Edición Génica / Rayos Infrarrojos Límite: Animals / Humans Idioma: En Año: 2024 Tipo del documento: Article